Website profile

Indian Pharma Post

Ajanta Pharma to hold 47th annual general meeting on July 16 Indian Pharma Post Get the latest News & Research on Pharma industry, Viewpoints, Events, Videos, statistics, indianpharmapost.com

  • 186articles · 30d
  • 21+ hour agolatest article
  • Aug 17, 2026earliest in window
  • 90%with images
  • 243avg words
articles per day
Categories
  • Medical 137
  • Health & Wellness 101
  • Economy, Business & Finance 79
  • Health 74
  • Business & Industrial 64
  • Finance & Business 32
  • Science & Technology 21
  • News 14
Bylines

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

@pharma_indian
indianpharmapost.com > hospitals > apollo-hospitals-navi-mumbai-launches-geriatric-oncology-clinic-for-specialised-cancer-care-21765

Apollo Hospitals Navi Mumbai launches geriatric oncology clinic for specialised cancer care

4+ day, 21+ hour ago   (308+ words) The hospital aims to expand access to multidisciplinary and personalised cancer care for India’s ageing population, balancing cancer control with treatment safety, functional independence, comfort and quality of life Apollo Hospitals Navi Mumbai has launched a dedicated Geriatric Oncology Clinic…...

@pharma_indian
indianpharmapost.com > regulatory > fda-moves-to-boost-estradiol-patch-supply-as-demand-surges-21754

FDA moves to boost estradiol patch supply as demand surges

5+ day, 9+ hour ago   (65+ words) Over the past year, the supply of FDA-approved estradiol transdermal patches has nearly doubled FDA moves to boost estradiol patch supply as demand surges Superluminal Medicines raises $60 million to push obesity drug into clinic Novartis’ pelacarsen trial fails to cut…...

@pharma_indian
indianpharmapost.com > biopharma > biocon-inks-10-year-deal-to-supply-breast-cancer-therapy-to-brazil-21757

Biocon inks 10-year deal to supply breast cancer therapy to Brazil

5+ day, 8+ hour ago   (256+ words) Biocon Limited has signed a landmark partnership agreement with Bahiafarma and Bionovis for Pertuzumab in Brazil. This collaboration marks a significant step forward in scaling the production and commercialization of this HER2-positive breast cancer therapy under the country's Productive Development…...

@pharma_indian
indianpharmapost.com > healthcare > roche-pharma-india-names-five-winners-of-third-edition-of-leap-oncology-programme-21753

Roche Pharma India names five winners of third edition of LEAP Oncology programme

6+ day, 6+ hour ago   (442+ words) Roche Pharma India has announced the winners of the third edition of its Leading Engagements to Advance Patient Care (LEAP) programme, recognising five oncology students for developing innovative solutions to challenges in cancer care. The third edition of LEAP invited…...

@pharma_indian
indianpharmapost.com > drug-approval > astrazeneca-breast-cancer-drug-wins-us-approval-after-trial-cuts-progression-risk-by-56-21745

AstraZeneca breast cancer drug wins US approval after trial cuts progression risk by 56%

6+ day, 13+ hour ago   (64+ words) The US Food and Drug Administration’s accelerated approval is based on results from the Phase III SERENA-6 trial Indian Immunologicals seeks probe into NSQ Abhayrab vials, says samples differ from genuine batch Dr. Jitendra Singh calls for early industry partnership…...

Google News
indianpharmapost.com > clinical-trials > summits-ivonescimab-delivers-overall-survival-win-against-pembrolizumab-in-phase-iii-lung-cancer-trial-21732

Summit’s ivonescimab delivers overall survival win against pembrolizumab in Phase III lung cancer trial

1+ week, 11+ hour ago   (68+ words) Indian Pharma Post Summit’s ivonescimab delivers overall survival win against pembrolizumab in Phase III lung cancer trial Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants Implementing a digital transformation in chemical operations to maximize profitability The…...

@pharma_indian
indianpharmapost.com > biopharma > evolved-therapeutics-selects-enpicom-platform-to-accelerate-antibody-discovery-21726

Evolved Therapeutics selects ENPICOM Platform to accelerate antibody discovery

1+ week, 18+ hour ago   (209+ words) The company said its growing experimental throughput requires digital infrastructure capable of rapidly converting large volumes of discovery data into actionable insights. Brandon Clavette, VP Research & Development at Evolved Therapeutics, said the company chose ENPICOM because the platform is purpose-built…...

@pharma_indian
indianpharmapost.com > news > astrazeneca-completes-dizal-deal-for-lung-cancer-drug-zegfrovy-21673

AstraZeneca completes Dizal deal for lung cancer drug Zegfrovy

1+ week, 4+ day ago   (60+ words) The deal gives AstraZeneca global control of a drug targeting a particularly aggressive form of lung cancer with significant unmet treatment needs Medtronic to invest $700 million in Hong Kong surgical robotics firm Scan.com raises $220 million to expand US medical…...

@pharma_indian
indianpharmapost.com > clinical-trials > zydus-saroglitazar-mg-clears-key-hurdle-in-global-mash-trial-21637

Zydus’ Saroglitazar Mg clears key hurdle in global MASH trial

1+ week, 6+ day ago   (73+ words) EVIDENCES-X trial met its primary endpoint, with a 26.5% treatment difference in MASH resolution without worsening of fibrosis Dr. Rajesh Nair appointed CEO of Park Group of Hospitals India cuts malaria cases and deaths by nearly 80% over a decade IPC launches…...

Google News
indianpharmapost.com > biopharma > cipla-inks-exclusive-licence-deal-with-sino-biopharma-for-her2-targeted-adc-21651

Cipla inks exclusive licence deal with Sino Biopharma for HER2-targeted ADC

1+ week, 6+ day ago   (341+ words) Partnership gives Cipla development and commercialisation rights for TQB2102 across India, South Africa and five other emerging markets Under the agreement, SBP Group subsidiary Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ) has granted Cipla exclusive rights to develop and commercialise…...